Methotrexate (for oral or injection use) — Patient Information (Australia)

Methotrexate is a well-established medicine used to treat several autoimmune and inflammatory conditions, and in some cases certain cancers. It is used in carefully selected people and is monitored to reduce the risk of side effects and to ensure it remains effective.

This guide is written for patients and carers. It explains what methotrexate does, how it works in the body, how it is typically taken, key safety considerations, and practical tips for everyday use in Australia.

Basic product information

• Medicine name: Methotrexate
• Common forms: tablets (oral) and injectable formulations (e.g., under the skin or into a muscle/vein depending on local product)
• Therapeutic classes: antimetabolite / disease-modifying antirheumatic drug (DMARD) and anticancer agent (depending on dose and indication)
• Brand names: There are various registered products in Australia; your pharmacist can confirm the exact brand and strength you have.
• Availability: Typically supplied through pharmacy channels with appropriate clinical oversight.

Important: Methotrexate regimens vary by condition. Many inflammatory uses are taken as a once-weekly dose, but the exact schedule depends on your diagnosis and strength. Always follow the specific directions provided with your medicine.

How methotrexate works (mechanism of action)

Methotrexate is an antimetabolite. After entering cells, it is converted to active forms that interfere with folate metabolism. This can affect cell growth and immune signalling.

In autoimmune diseases, methotrexate’s benefits are mainly linked to its ability to reduce inflammatory activity and modulate the immune system. In cancer treatments, higher-dose schedules can also target rapidly dividing cells.

• Folate pathway inhibition: methotrexate reduces the availability of folate derivatives needed for DNA synthesis.
• Immune modulation: it can suppress overactive immune responses that drive joint and tissue inflammation.
• Gradual benefit: improvement often takes weeks as inflammation settles and the immune response changes.

Pharmacokinetics (how the body handles methotrexate)

Pharmacokinetics describes what the body does to a medicine—absorption, distribution, metabolism, and excretion. Understanding these processes helps explain dosing schedules and monitoring.

Because methotrexate is mainly cleared by the kidneys, people with reduced kidney function may require dose adjustments and closer monitoring.

Typical uses (indications)

Methotrexate is used across multiple therapeutic areas. In Australia, it is commonly prescribed for chronic inflammatory conditions where it can help control disease activity and reduce long-term joint or organ damage.

Common indications include:

• Rheumatoid arthritis
• Polyarticular juvenile idiopathic arthritis (in appropriate age groups and with specialist oversight)
• Psoriatic arthritis
• Severe psoriasis (especially forms not adequately controlled with other options)
• Other inflammatory or autoimmune conditions in selected patients (based on clinical judgement and guideline recommendations)

In oncology, methotrexate may be used as part of combination regimens at different dose levels and schedules. The details of cancer regimens differ substantially from low-dose weekly schedules used in many autoimmune conditions.

How to take methotrexate: timing and dosing principles

Methotrexate dosing schedules differ by condition and formulation. Many inflammatory/autoimmune uses are taken once per week. This is a crucial safety point.

Key timing points:

• Choose a single weekly day: Take methotrexate on the same day each week unless your clinician instructs otherwise.
• Do not take it more frequently: Taking extra doses by mistake is a common cause of serious adverse effects.
• Set reminders: Use a calendar alert or weekly reminder system.
• Consistency matters: Try to take it the same way each time (for example, with or without food), unless your clinician or pharmacist advises changes.

Dosing varies: Your prescribed dose and number of tablets or injection volume depend on your condition, blood test results, kidney and liver function, and how you respond.

Typical dosing (patient-friendly overview)

Because exact regimens depend on your diagnosis and product strength, this section explains common principles rather than personal instructions.

• Autoimmune / inflammatory conditions: Frequently prescribed as a low-dose once-weekly regimen. The dose may be increased gradually if needed and tolerated.
• Some psoriasis or arthritis cases: Dosing schedules may vary, sometimes combined with other therapies.
• Children: Dosing is usually weight-based and requires close specialist supervision.
• Cancer therapy: Often uses higher doses with specific safety measures (for example, “rescue” folinic acid in some protocols). This differs from typical weekly DMARD dosing.

Do not adjust your dose yourself. Dose changes should be guided by your clinician and supported by monitoring blood tests.

Food interactions

Food can influence oral medicine absorption and stomach tolerance for some people. For methotrexate, this can vary by formulation and individual factors.

• Take as directed: If your pharmacist or clinician advises taking methotrexate with food, follow that plan.
• Be consistent: Switching between with-food and without-food each week may change how much is absorbed.
• Manage nausea: If methotrexate causes nausea, your clinician may suggest supportive strategies (e.g., timing adjustments, anti-nausea measures, or folate supplementation).

If you notice persistent stomach upset, mouth ulcers, or vomiting after dosing, contact your healthcare team rather than stopping abruptly.

Alcohol and medicine interactions

Alcohol

Alcohol can increase the risk of liver irritation when combined with medicines that may affect liver function, including methotrexate. Many patients are advised to limit or avoid alcohol while using methotrexate, depending on their liver blood tests, dose, and overall health.

• Ask your clinician: Your safe alcohol allowance may differ from other patients.
• Avoid binge drinking: Even if occasional drinks are permitted, large amounts in one sitting may increase risk.
• Report symptoms: Tell your doctor promptly if you develop unusual fatigue, yellowing of skin/eyes, dark urine, or right upper belly pain.

Medicine interactions (common examples)

Methotrexate can interact with other medicines that affect kidney function, the gut, or folate pathways. It’s essential to check all medicines (including over-the-counter products and supplements).

Examples of interaction concerns include:

• Non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen, naproxen): may affect kidney handling of drugs and increase side-effect risk in some situations, especially with certain doses and in people with kidney impairment.
• Some antibiotics (e.g., trimethoprim-sulfamethoxazole): may increase risk of blood count suppression.
• Proton pump inhibitors and some acid reducers: can sometimes affect methotrexate levels in certain circumstances.
• Folate supplements: these are often used to reduce side effects in weekly regimens. Do not change folate plans without advice.
• Other immune-modulating medicines: may increase infection risk depending on combination.
• Herbal products and high-dose vitamins: some may affect liver or blood counts.

Always tell your pharmacist about:

• all prescriptions you take
• over-the-counter pain relievers and cold/flu products
• supplements (including “natural” products)
• recent vaccinations or planned vaccinations

Safety profile and monitoring

Methotrexate has a well-characterised safety profile, especially when used at the low doses typically used for inflammatory conditions with appropriate monitoring. The most important risks relate to the liver, blood cells, lungs, and gastrointestinal or mouth side effects.

Common or expected side effects

• Nausea, reduced appetite
• Fatigue
• Mouth ulcers or mouth soreness
• Headache (varies by person)
• Hair thinning (less common; may be dose-related)
• Skin sensitivity in some patients

Serious but less common risks (seek medical advice urgently)

• Infection (fever, chills, persistent cough, shortness of breath): methotrexate can affect immune function.
• Breathing or lung symptoms (new cough, breathlessness, chest tightness): rare lung inflammation can occur.
• Severe mouth sores or widespread rash
• Signs of liver injury (yellowing eyes/skin, dark urine, severe upper abdominal pain)
• Severe low blood counts (unusual bruising, bleeding, significant weakness): requires urgent assessment.

Monitoring schedule (typical practice in Australia)

Many clinicians monitor blood tests at intervals, especially during the first months or after dose changes. Monitoring helps detect early liver or blood count changes.

• Full blood count (FBC) (for blood cell levels)
• Kidney function (especially creatinine/eGFR)
• Liver function tests
• Other tests as indicated (e.g., imaging or additional checks if symptoms arise)

If you miss a monitoring appointment, contact your clinician promptly to discuss whether you should continue until results are reviewed.

Practical use tips (day-to-day guidance)

• Use a “weekly checklist”: On dosing day, confirm you’re taking the weekly dose only (not an extra dose).
• Consider a pill organiser specifically for weekly medicines, and keep methotrexate clearly separated from daily medications.
• Hydration and kidney health: Drink adequate fluids and report dehydration, diarrhoea, or vomiting, which can affect kidney function.
• Dental hygiene: Gentle brushing and regular dental care may help reduce the impact of mouth sores.
• Sun protection: Some patients may be more sensitive to sunlight; use sunscreen and protective clothing if advised.
• Track side effects: Keep notes about nausea, mouth ulcers, infections, or unusual symptoms, and share them with your healthcare team.
• Don’t stop suddenly without advice: Stopping methotrexate can lead to flare-ups of inflammation.

Folate (vitamin B9) support: Many treatment plans include folate (or related supplementation) to reduce side effects while keeping effectiveness. Only change your folate plan if your clinician recommends it.

What to do if you miss a dose

Because methotrexate is often taken once weekly, missed-dose guidance depends on your schedule and the timing of the missed dose.

• Contact your pharmacist or clinician: They can advise based on the day you missed and when your next weekly dose is due.
• Do not double up unless specifically instructed.
• If you accidentally take an extra dose: seek prompt medical advice, especially if you develop mouth ulcers, severe nausea, or unusual bruising/bleeding.

Alternative treatment options

If methotrexate is not tolerated, is ineffective, or is unsuitable for a person due to health factors, there are other options. Your clinician will choose alternatives based on your diagnosis, disease severity, and risk profile.

Potential alternatives (depending on condition) include:

• Other DMARDs (for example, sulfasalazine or leflunomide)
• Biologic medicines that target specific inflammatory pathways
• Targeted synthetic DMARDs (for example, certain kinase inhibitors, depending on eligibility)
• Short-term “bridging” therapies (such as corticosteroids) to control flares while longer-term treatments take effect
• Supportive therapies including physiotherapy, pain management strategies, and lifestyle measures

Switching therapies should be planned to balance effectiveness with safety, including infection risk and monitoring requirements.

Market and legal context in Australia (patient overview)

In Australia, methotrexate is available through pharmacy supply channels under medicines legislation and prescribing/dispensing requirements relevant to your indication and product. Use is typically guided by professional oversight and monitoring.

• Clinical monitoring is a standard part of safe use for inflammatory indications.
• Clear labelling and directions are important to prevent dosing errors, particularly because dosing is commonly weekly.
• Pharmacists play an important role in checking interactions and helping ensure correct administration.

Supply and availability can also depend on product type (tablets versus injection), brand, and local stock levels.

Recent guidance and updates (how to stay current)

Clinical guidance for methotrexate can evolve based on new evidence, safety monitoring practices, and changes in overall treatment strategies for autoimmune disease. In Australia, clinicians typically follow:

• national and international rheumatology and dermatology guidance
• updates from medicines safety authorities and professional bodies
• local protocols for blood testing frequency and supportive measures

Because your situation is unique, the best “current guidance” is the plan your clinician provides for your diagnosis and health factors. If you want an update, ask your treating team when you next review your treatment.

Delivery and availability (online pharmacy information)

Methotrexate products may be supplied as tablets or injections depending on the formulation you require. Availability can vary by strength and brand.

• Processing time: Orders may require verification and may take slightly longer during peak periods or when particular strengths are low in stock.
• Delivery: Delivery timeframes depend on your location and the courier service available.
• Packaging: Medicines are typically packaged to protect them during transit and to support safe identification on arrival.

If you need an injection product or a specific strength, contact customer support so we can help confirm availability and recommended storage conditions.

FAQ — Methotrexate

1) Is methotrexate taken once a week?

For many inflammatory conditions, methotrexate is taken once weekly. However, dosing schedules can vary for different indications and formulations. Follow your specific directions and do not switch to a daily schedule.

2) How long does it take to work?

Many patients begin to notice improvement within a few weeks, but full benefits may take several months. If you have no improvement or worsening symptoms, discuss this with your clinician rather than stopping.

3) Can I take folate while on methotrexate?

Many treatment plans include folate (or related vitamin supplementation) to reduce side effects. Do not start, stop, or change dose frequency of folate without your clinician’s advice.

4) What blood tests are needed?

Monitoring commonly includes a full blood count, liver function tests, and kidney function. The exact schedule depends on your health, dose, and how stable your condition is.

5) Is it safe to drink alcohol?

Alcohol may increase liver-related risks. Many people are advised to limit or avoid alcohol while on methotrexate. Your clinician can advise a personalised recommendation based on your liver tests and dose.

6) Can I take ibuprofen or other painkillers?

Pain relief options depend on your kidney function and overall medication list. Some NSAIDs may be used with caution, but interactions can occur. Ask your pharmacist before combining medicines.

7) What should I do if I get a fever or feel unwell?

Contact your healthcare team promptly if you develop fever, chills, signs of infection, or shortness of breath. Because methotrexate affects the immune system, infections may need earlier assessment.

8) What if I get mouth ulcers?

Mouth ulcers can be a sign your dose isn’t being tolerated. Contact your clinician or pharmacist. Prompt management can prevent complications.

9) Can methotrexate cause hair loss?

Hair thinning can occur in some people. It is often reversible after adjustments to treatment, but severity varies.

10) Are there alternatives if methotrexate doesn’t suit me?

Yes. Depending on your condition, other DMARDs, biologic therapies, or targeted medicines may be considered. Your clinician will weigh risks and benefits for your specific situation.

Need help choosing the right approach?

If you’re unsure about how to take methotrexate, how often to have monitoring blood tests, or whether your medicines and supplements could interact, speak with your pharmacist. They can help you confirm the correct schedule and reduce preventable dosing and interaction risks.

For urgent symptoms (such as signs of severe infection, breathing problems, or suspected overdose), seek medical help immediately.